Purification and crystallization of cyclin-dependent kinase inhibitor p21

Protein Science

Volumn 5, Issue 9, 1996, Pages 1928-1930

  Mayrose, Dale R ^a   Nichols, Michael A ^a   Xiong, Yue ^a   Ke, Hengming ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

cell cycle; crystallization; cyclin dependent kinase inhibitor; X ray diffraction

Indexed keywords

CYCLINE;

ARTICLE; CELL CYCLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DNA REPLICATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN QUATERNARY STRUCTURE; PROTEIN STABILITY; X RAY DIFFRACTION;

EID: 0029786705     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560050920     Document Type: Article

References (27)

1. Aprelikova O, Xiong Y, Liu ET. 1995. Both p16 and p21 families of CDK inhibitors block CDK phosphorylation by the CDK activating kinase (CAK). J Biol Chem 270:18195-18197.
2. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557.
3. Chen J, Jackson PK, Kirschner MW, Dutta A. 1995 Separate domains of p21 involved in the inhibition of cdk kinase and PCNA. Nature 374:386-388.
4. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. 1995. Transforming growth factor b induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92:5545-5549.
5. CIP1/WAF1 undergo normal development, but are defective in G1 check-point control. Cell 82:675-684.
6. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Lin DM, Mercer WE, Kinzler KWV, Vogelstein B. 1993 WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
7. Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ, O'Donell M, Hurwitz J. 1994. Cdk-interacting protein directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase d holoenzyme. Proc. Natl Acad Sci USA 91:8655-8659.
8. Gu Y, Turck CW, Morgan DO. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710.
9. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB. 1995. Terminal cell cycle arrest of skeletal muscle correlates with induction of p21 by MyoD. Science 267:1018-1021.
10. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
11. Hirai H, Roussel MF, Kato J, Ashmun RA, Sherr CJ. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15:2672-2681.
12. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142-153.
13. CIP1. Nature 375:159-161.
14. Sdr1/CIP1/WAF1. EMBO J 14:555-563.
15. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. 1994. Cloning of senescent cell-derived inhibitor of DNA synthesis using an expression screen. Exp Cell Res 211:90-98.
16. Serrano M, Hannon GJ, Beach D. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707.
17. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases Genes Dev 9:1149-1163.
18. Shiyanov P, Bagchi S, Adami G, Kokontis J, Hay N, Arroyo M, Morozov A, Raychaudhuri P. 1996. p21 disrupts the interaction between cdk2 and the E2F-p130 complex. Mol Cell Biol 16 737-744.
19. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW. 1990. RNA polymerase to direct expression of cloned genes. Methods Enzymol 185:60-89.
20. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ. 1996. CCAAT/enhancer-binding protein a (C/EBPa) inhibits cell proliferation through the p21 (WAF1/CIP-1/SDI-1) protein. Genes Dev 10:804-815
21. Waga S, Hannon GJ, Beach D, Stillman B. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA Nature 369:574-578.
22. 1 arrest in human cancer cells. Cancer Res 55:5187-5190.
23. Xiong Y, Zhang H, Beach D. 1992. D-type cyclins associated with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514.
24. Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D. 1993a. p21 is a universal inhibitor of the cyclin kinases. Nature 366:701-704.
25. Xiong Y, Zhang H, Beach D. 1993b. Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7:1572-1583.
26. Zhang H, Xiong Y, Beach D. 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4:897-906.
27. CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev 9:1740-1752.